Evidence map›Paper›PMID 40864051›Full record

ReviewToxins2025

Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia.

Jarosław Sławek, Iga Alicja Łobińska, Michał Schinwelski, Joanna Kopcewicz-Wiśniewska, Anna Castagna

Erratum issuedAbstract readReviewCase Reports
In one paragraph

Review in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jarosław SławekDivision of Neurological-Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Iga Alicja ŁobińskaMedical Faculty, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Michał SchinwelskiNeurocentrum-Miwomed, Neurological Clinic, 80-207 Gdańsk, Poland.ORCID 0000-0003-3695-2612
Joanna Kopcewicz-WiśniewskaDepartment of Neurology & Stroke, St. Adalbert Hospital, Copernicus Ltd., 80-462 Gdańsk, Poland.
Anna CastagnaIRCCS Fondazione Don Carlo Gnocchi, Onlus, 20162 Milan, Italy.ORCID 0000-0003-0216-8205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axial truncal dystonia can present as either flexion or extension, often with a tendency toward lateral movement. Flexion dystonia is more common and may represent a clinical spectrum associated with parkinsonism. In contrast, extensor trunk dystonia is less frequent and exhibits a diverse range of causes. In this paper, we reviewed the literature on axial extensor trunk dystonia. We identified 11 studies involving 49 patients, of which only 10 had idiopathic trunk dystonia. Treatment with botulinum neurotoxin A (BoNT/A) emerged as the most effective therapy; however, many studies did not provide detailed descriptions of the treatment (4/11) and follow-up periods were not specified or short term (up to one-two years). We present four new, well-documented patients with the idiopathic form of extensor trunk dystonia who were treated with BoNT/A with moderate to significant effect according to Global Clinical Impression scale (GCI) and Burke-Fahn-Marsden (BFM) dystonia scale. These cases include long-term follow-up for three patients, all without any adverse events. While the diagnostic process and treatment can be challenging, we recommend using BoNT/A with adjusted doses tailored to the appropriate muscle groups as a first-line treatment.

Indexed as

Botulinum Toxins, Type ADystoniaDystonic DisordersNeuromuscular AgentsAdultAgedFemaleHumansMaleMiddle AgedTreatment OutcomeBotulinum Toxins, Type ANeuromuscular Agentsaxial dystoniaaxial extensor dystoniabotulinum neurotoxindystoniatruncal dystonia

Identifiers

PMID40864051
PMCPMC12389960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.